Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

5drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: nirmatrelvir/ritonavir ×

nirmatrelvir/ritonavir

This drug is selected. Its supporting articles are shown below.

nirmatrelvir/ritonavir3

Articles mentioning nirmatrelvir/ritonavir

3 articles · page 1 of 1

Rapid establishment of public sector COVID-19 test-and-treatment programmes across seven low- and middle-income countries: implementation strategies and program monitoring results

bmjgh · abstract · 2025-12-10 · 3 matching annotations

96.7%

nirmatrelvir/ritonavir COVID-19 SARS-CoV-2

…facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing…

Mixed methods implementation research of oral antiviral treatment for COVID-19 in low- and middle-income countries: a study protocol

bmjopen · abstract · 2025-09-18 · 1 matching annotations

97.8%

nirmatrelvir/ritonavir COVID-19 Duke University Institutional Review Board oral antiviral treatment

…hallenges of COVID-19 Test and Treat (T&T) programmes. In 2022, nirmatrelvir/ritonavir was provided as standard of care for mild to moderate COVID-19 …

Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings

bmjopen · abstract · 2025-08-03 · 1 matching annotations

92.2%

nirmatrelvir/ritonavir Paxlovid SARS-CoV-2 COVID-19 Clinical Trials Ontario Unity Health Toronto Research Ethics Board

…ent Therapeutics Committee. The first therapeutic arm evaluates nirmatrelvir/ritonavir (Paxlovid), administered two times per day for 5 days. The seco…